Reference
[1] Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood. 1997;90(1):354-71.
[2] Cortelazzo S, Ponzoni M, Ferreri AJM, Hoelzer D. Lymphoblastic lymphoma. Critical Reviews in Oncology/Hematology. 2011;79(3):330-43.
[3] Bassan R, Maino E, Cortelazzo S. Lymphoblastic lymphoma: an updated review on biology, diagnosis, and treatment. European Journal of Haematology. 2016;96(5):447-60.
[4] Maitra A, McKenna RW, Weinberg AG, Schneider NR, Kroft SH. Precursor B-cell lymphoblastic lymphoma. A study of nine cases lacking blood and bone marrow involvement and review of the literature. American journal of clinical pathology. 2001;115(6):868-75.
[5] RARECAREnet. Avaialble at: http://www.rarecarenet.eu/rarecarenet/
[6] Kim J-Y, Kim YC, Lee E-S. Precursor B-cell lymphoblastic lymphoma involving the skin. J Cutan Pathol. 2006;33(9):649–53.
[7] Siah TW, Windebank KP, Menon G, Leech S. A scalp nodule in a 4-year-old boy. Precursor B-cell lymphoblastic lymphoma. Pediatr Dermatol. 2013;30(1):135–6.
[8] Cortelazzo S, Ferreri A, Hoelzer D, Ponzoni M. Lymphoblastic lymphoma. Crit Rev Oncol Hematol. 2017;113:304–17.
[9] Ducassou S, Ferlay C, Bergeron C, Girard S, Laureys G, Pacquement H, et al. Clinical presentation, evolution, and prognosis of precursor B-cell lymphoblastic lymphoma in trials LMT96, EORTC 58881, and EORTC 58951. British journal of haematology. 2011;152(4):441-51.
[10] Soslow RA, Baergen RN, Warnke RA. B-lineage lymphoblastic lymphoma is a clinicopathologic entity distinct from other histologically similar aggressive lymphomas with blastic morphology. Cancer. 1999;85(12):2648-54.
[11] Nathwani BN, Diamond LW, Winberg CD, Kim H, Bearman RM, Glick JH, et al. Lymphoblastic lymphoma: A clinicopathologic study of 95 patients. Cancer. 1981;48(11):2347-57.
[12] Lin P, Jones D, Dorfman DM, Medeiros LJ. Precursor B-cell lymphoblastic lymphoma: a predominantly extranodal tumor with low propensity for leukemic involvement. The American journal of surgical pathology. 2000;24(11):1480-90.
[13] Lee WJ, Moon HR, Won CH, Chang SE, Choi JH, Moon KC, et al. Precursor B- or T-lymphoblastic lymphoma presenting with cutaneous involvement: A series of 13 cases including 7 cases of cutaneous T-lymphoblastic lymphoma. Journal of the American Academy of Dermatology. 2014;70(2):318-25.
[14] Boccara O, Laloum-Grynberg E, Jeudy G, Aubriot-Lorton M-H, Vabres P, de Prost Y, et al. Cutaneous B-cell lymphoblastic lymphoma in children: A rare diagnosis. Journal of the American Academy of Dermatology. 2012;66(1):51-7.
[13] Reiter A, Schrappe M, Ludwig WD, Tiemann M, Parwaresch R, Zimmermann M, et al. Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood. 2000;95(2):416-21.